The DOI matches its Crossref record; 90 of the 90 references it cites were found in a registry or an index.
Bone sarcomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
TNM Classification of Malignant Tumors
Carter, D. (1998) · The American Journal of Surgical Pathology · doi:10.1097/00000478-199810000-00016 · Cited by 6,330
WHO classification of tumours of soft tissue and bone
Fletcher, C. D. �. (2013) · Cited by 2,874
A System for the Surgical Staging of Musculoskeletal Sarcoma
ENNEKING, W. F., SPANIER, S. S., & GOODMAN, M. A. (1980) · Clinical Orthopaedics and Related Research · doi:10.1097/00003086-198011000-00013 · Cited by 2,500
Bielack, S. S., Kempf-Bielack, B., Delling, G., Exner, G. U., Flege, S., Helmke, K., Kotz, R., Salzer-Kuntschik, M., Werner, M., Winkelmann, W., et al. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.2002.20.3.776 · Cited by 2,393 · cited 1×
“The extent of histological response to preoperative chemotherapy predicts survival [21, 23, 24].”
Grier, H. E., Krailo, M. D., Tarbell, N. J., Link, M. P., Fryer, C. J. H., Pritchard, D. J., Gebhardt, M. C., Dickman, P. S., Perlman, E. J., Meyers, P. A., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa020890 · Cited by 1,328
Cotterill, S. J., Ahrens, S., Paulussen, M., Jürgens, H. F., Voûte, P. A., Gadner, H., & Craft, A. W. (2000) · Journal of Clinical Oncology · doi:10.1200/jco.2000.18.17.3108 · Cited by 1,040
Kager, L., Zoubek, A., Pötschger, U., Kastner, U., Flege, S., Kempf-Bielack, B., Branscheid, D., Kotz, R., Salzer-Kuntschik, M., Winkelmann, W., et al. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.08.132 · Cited by 934
The Clinical Approach Towards Chondrosarcoma
Gelderblom, H., Hogendoorn, P. C. W., Dijkstra, S. D., van Rijswijk, C. S., Krol, A. D., Taminiau, A. H. M., & Bovée, J. V. M. G. (2008) · The Oncologist · doi:10.1634/theoncologist.2007-0237 · Cited by 756
Meyers, P. A., Schwartz, C. L., Krailo, M. D., Healey, J. H., Bernstein, M. L., Betcher, D., Ferguson, W. S., Gebhardt, M. C., Goorin, A. M., Harris, M., et al. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2008.14.0095 · Cited by 752
Sorensen, P. H. B., Lessnick, S. L., Lopez-Terrada, D., Liu, X. F., Triche, T. J., & Denny, C. T. (1994) · Nature Genetics · doi:10.1038/ng0294-146 · Cited by 747
Common Musculoskeletal Tumors of Childhood and Adolescence
Arndt, C. A. S., & Crist, W. M. (1999) · New England Journal of Medicine · doi:10.1056/nejm199907293410507 · Cited by 657
The hazards of biopsy in patients with malignant primary bone and soft-tissue tumors.
Mankin, H. J., Lange, T. A., & Spanier, S. S. (1982) · The Journal of Bone & Joint Surgery · doi:10.2106/00004623-198264080-00002 · Cited by 648
Kempf-Bielack, B., Bielack, S. S., Jürgens, H., Branscheid, D., Berdel, W. E., Exner, G. U., Göbel, U., Helmke, K., Jundt, G., Kabisch, H., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.04.063 · Cited by 643 · cited 3×
“In the two largest reported series, the use of second-line chemotherapy correlated with limited prolongation of survival in patients with inoperable metastatic recurrences, while a positive correlation in operable disease was observed in only one of the two [41, 42].”
Dykewicz, C. A. (2001) · Clinical Infectious Diseases · doi:10.1086/321805 · Cited by 636
Brachyury, a crucial regulator of notochordal development, is a novel biomarker for chordomas
Vujovic, S., Henderson, S., Presneau, N., Odell, E., Jacques, T., Tirabosco, R., Boshoff, C., & Flanagan, A. (2006) · The Journal of Pathology · doi:10.1002/path.1969 · Cited by 589
Chawla, S., Henshaw, R., Seeger, L., Choy, E., Blay, J.-Y., Ferrari, S., Kroep, J., Grimer, R., Reichardt, P., Rutkowski, P., et al. (2013) · The Lancet Oncology · doi:10.1016/s1470-2045(13)70277-8 · Cited by 587
Nesbit, M. E., Gehan, E. A., Burgert, E. O., Vietti, T. J., Cangir, A., Tefft, M., Evans, R., Thomas, P., Askin, F. B., & Kissane, J. M. (1990) · Journal of Clinical Oncology · doi:10.1200/jco.1990.8.10.1664 · Cited by 570
Primary Disseminated Multifocal Ewing Sarcoma: Results of the Euro-EWING 99 Trial
Ladenstein, R., Pötschger, U., Le Deley, M. C., Whelan, J., Paulussen, M., Oberlin, O., van den Berg, H., Dirksen, U., Hjorth, L., Michon, J., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.22.9864 · Cited by 540
Ewing's Sarcoma Family of Tumors: Current Management
Bernstein, M., Kovar, H., Paulussen, M., Randall, R. L., Schuck, A., Teot, L. A., & Juergensg, H. (2006) · The Oncologist · doi:10.1634/theoncologist.11-5-503 · Cited by 520
Ferrari, S., Smeland, S., Mercuri, M., Bertoni, F., Longhi, A., Ruggieri, P., Alvegard, T. A., Picci, P., Capanna, R., Bernini, G., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2004.00.5785 · Cited by 435
Goorin, A. M., Schwartzentruber, D. J., Devidas, M., Gebhardt, M. C., Ayala, A. G., Harris, M. B., Helman, L. J., Grier, H. E., & Link, M. P. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.08.165 · Cited by 395
OPERATIVE MANAGEMENT OF SACRAL CHORDOMA
FUCHS, B., DICKEY, I. D., YASZEMSKI, M. J., INWARDS, C. Y., & SIM, F. H. (2005) · The Journal of Bone and Joint Surgery-American Volume · doi:10.2106/00004623-200510000-00009 · Cited by 362
Diagnostic Imaging of Solitary Tumors of the Spine: What to Do and Say
Rodallec, M. H., Feydy, A., Larousserie, F., Anract, P., Campagna, R., Babinet, A., Zins, M., & Drapé, J.-L. (2008) · RadioGraphics · doi:10.1148/rg.284075156 · Cited by 360
Schuck, A., Ahrens, S., Paulussen, M., Kuhlen, M., Könemann, S., Rübe, C., Winkelmann, W., Kotz, R., Dunst, J., Willich, N., et al. (2003) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/s0360-3016(02)03797-5 · Cited by 348
Lewis, I. J., Nooij, M. A., Whelan, J., Sydes, M. R., Grimer, R., Hogendoorn, P. C. W., Memon, M. A., Weeden, S., Uscinska, B. M., van Glabbeke, M., et al. (2007) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djk015 · Cited by 346
Bacci, G., Ferrari, S., Bertoni, F., Rimondini, S., Longhi, A., Bacchini, P., Forni, C., Manfrini, M., Donati, D., & Picci, P. (2000) · Journal of Clinical Oncology · doi:10.1200/jco.2000.18.1.4 · Cited by 327
Postrelapse Survival in Osteosarcoma of the Extremities: Prognostic Factors for Long-Term Survival
Ferrari, S., Briccoli, A., Mercuri, M., Bertoni, F., Picci, P., Tienghi, A., Del Prever, A. B., Fagioli, F., Comandone, A., & Bacci, G. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.03.141 · Cited by 316
Risk of recurrence and survival after relapse in patients with Ewing sarcoma
Stahl, M., Ranft, A., Paulussen, M., Bölling, T., Vieth, V., Bielack, S., Görtitz, I., Braun‐Munzinger, G., Hardes, J., Jürgens, H., et al. (2011) · Pediatric Blood & Cancer · doi:10.1002/pbc.23040 · Cited by 315
Picci, P., Sangiorgi, L., Rougraff, B. T., Neff, J. R., Casadei, R., & Campanacci, M. (1994) · Journal of Clinical Oncology · doi:10.1200/jco.1994.12.12.2699 · Cited by 300
Turc-Carel, C., Philip, I., Berger, M.-P., Philip, T., & Lenoir, G. M. (1984) · Cancer Genetics and Cytogenetics · doi:10.1016/0165-4608(84)90002-5 · Cited by 291
Effectiveness of Carbon Ion Radiotherapy in the Treatment of Skull-Base Chordomas
Schulz-Ertner, D., Karger, C. P., Feuerhake, A., Nikoghosyan, A., Combs, S. E., Jäkel, O., Edler, L., Scholz, M., & Debus, J. (2007) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2006.12.059 · Cited by 290
Ares, C., Hug, E. B., Lomax, A. J., Bolsi, A., Timmermann, B., Rutz, H. P., Schuller, J. C., Pedroni, E., & Goitein, G. (2009) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2008.12.055 · Cited by 279
Phase II Study of Imatinib in Advanced Chordoma
Stacchiotti, S., Longhi, A., Ferraresi, V., Grignani, G., Comandone, A., Stupp, R., Bertuzzi, A., Tamborini, E., Pilotti, S., Messina, A., et al. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2011.35.3656 · Cited by 276
Phase II Study of High-Dose Photon/Proton Radiotherapy in the Management of Spine Sarcomas
DeLaney, T. F., Liebsch, N. J., Pedlow, F. X., Adams, J., Dean, S., Yeap, B. Y., McManus, P., Rosenberg, A. E., Nielsen, G. P., Harmon, D. C., et al. (2009) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2008.08.058 · Cited by 264
Paulussen, M., Craft, A. W., Lewis, I., Hackshaw, A., Douglas, C., Dunst, J., Schuck, A., Winkelmann, W., Köhler, G., Poremba, C., et al. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2008.16.5720 · Cited by 263
Eefting, D., Schrage, Y. M., Geirnaerdt, M. J. A., Le Cessie, S., Taminiau, A. H. M., Bovée, J. V. M. G., & Hogendoorn, P. C. W. (2009) · American Journal of Surgical Pathology · doi:10.1097/pas.0b013e31817eec2b · Cited by 261
Paulussen, M., Ahrens, S., Craft, A. W., Dunst, J., Fröhlich, B., Jabar, S., Rübe, C., Winkelmann, W., Wissing, S., Zoubek, A., et al. (1998) · Journal of Clinical Oncology · doi:10.1200/jco.1998.16.9.3044 · Cited by 249
Fuchs, B., & Pritchard, D. J. (2002) · Clinical Orthopaedics and Related Research · doi:10.1097/00003086-200204000-00007 · Cited by 248
Dedifferentiated chondrosarcoma: Prognostic factors and outcome from a European group
Grimer, R. J., Gosheger, G., Taminiau, A., Biau, D., Matejovsky, Z., Kollender, Y., San-Julian, M., Gherlinzoni, F., & Ferrari, C. (2007) · European Journal of Cancer · doi:10.1016/j.ejca.2007.06.016 · Cited by 235
Cartilaginous Tumors: Fast Contrast-enhanced MR Imaging
Geirnaerdt, M. J. A., Hogendoorn, P. C. W., Bloem, J. L., Taminiau, A. H. M., & van der Woude, H.-J. (2000) · Radiology · doi:10.1148/radiology.214.2.r00fe12539 · Cited by 230
Cangir, A., Vietti, T. J., Gehan, E. A., Burgert, E. O., Thomas, P., Tefft, M., Nesbit, M. E., Kissane, J., & Pritchard, D. (1990) · Cancer · doi:10.1002/1097-0142(19900901)66:5<887::aid-cncr2820660513>3.0.co;2-r · Cited by 217
Current strategies of chemotherapy in osteosarcoma
Carrle, D., & Bielack, S. S. (2006) · International Orthopaedics · doi:10.1007/s00264-006-0192-x · Cited by 217
Translocation involving chromosome 22 in Ewing's Sarcoma. A cytogenetic study of four fresh tumors
Aurias, A., Rimbaut, C., Buffe, D., Zucker, J.-M., & Mazabraud, A. (1984) · Cancer Genetics and Cytogenetics · doi:10.1016/0165-4608(84)90003-7 · Cited by 215
Osteosarcoma in Paget's Disease of Bone
Hansen, M. F., Seton, M., & Merchant, A. (2006) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.06s211 · Cited by 212
Bovée, J. V., Cleton-Jansen, A.-M., Taminiau, A. H., & Hogendoorn, P. C. (2005) · The Lancet Oncology · doi:10.1016/s1470-2045(05)70282-5 · Cited by 211
Le Deley, M.-C., Delattre, O., Schaefer, K.-L., Burchill, S. A., Koehler, G., Hogendoorn, P. C. W., Lion, T., Poremba, C., Marandet, J., Ballet, S., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.23.3585 · Cited by 199
Temozolomide and intravenous irinotecan for treatment of advanced Ewing sarcoma
Wagner, L. M., McAllister, N., Goldsby, R. E., Rausen, A. R., McNall‐Knapp, R. Y., McCarville, M. B., & Albritton, K. (2007) · Pediatric Blood & Cancer · doi:10.1002/pbc.20697 · Cited by 197
Dedifferentiated Chondrosarcoma: The Role of Chemotherapy with Updated Outcomes
Dickey, I. D., Rose, P. S., Fuchs, B., Wold, L. E., Okuno, S. H., Sim, F. H., & Scully, S. P. (2004) · The Journal of Bone and Joint Surgery-American Volume · doi:10.2106/00004623-200411000-00008 · Cited by 194
Osteosarcoma over the age of forty
Grimer, R. J., Cannon, S. R., Taminiau, A. M., Bielack, S., Kempf-Bielack, B., Windhager, R., Dominkus, M., Saeter, G., Bauer, H., Meller, I., et al. (2003) · European Journal of Cancer · doi:10.1016/s0959-8049(02)00478-1 · Cited by 188 · cited 1×
“The multimodal treatment principles detailed above were generated in children, adolescents, and young adults with highgrade central osteosarcoma, but also relate to adults at least up to the age of 60 [39] [III, B].”
Meyer, J. S., Nadel, H. R., Marina, N., Womer, R. B., Brown, K. L. B., Eary, J. F., Gorlick, R., Grier, H. E., Randall, R. L., Lawlor, E. R., et al. (2008) · Pediatric Blood & Cancer · doi:10.1002/pbc.21596 · Cited by 180
van der Woude, H. J., Bloem, J. L., Verstraete, K. L., Taminiau, A. H., Nooy, M. A., & Hogendoorn, P. C. (1995) · American Journal of Roentgenology · doi:10.2214/ajr.165.3.7645476 · Cited by 178
Prognostic factors in localized extremity osteosarcoma: A systematic review
Bramer, J. A. M., van Linge, J. H., Grimer, R. J., & Scholten, R. J. P. M. (2009) · European Journal of Surgical Oncology (EJSO) · doi:10.1016/j.ejso.2009.01.011 · Cited by 177
Ugoretz, R. (2002) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.287.24.3266 · Cited by 177
Topotecan and cyclophosphamide in patients with refractory or relapsed Ewing tumors
Hunold, A., Weddeling, N., Paulussen, M., Ranft, A., Liebscher, C., & Jürgens, H. (2006) · Pediatric Blood & Cancer · doi:10.1002/pbc.20719 · Cited by 168
Haeusler, J., Ranft, A., Boelling, T., Gosheger, G., Braun‐Munzinger, G., Vieth, V., Burdach, S., van den Berg, H., Juergens, H., & Dirksen, U. (2010) · Cancer · doi:10.1002/cncr.24740 · Cited by 166
Bacci, G., Forni, C., Longhi, A., Ferrari, S., Donati, D., De Paolis, M., Barbieri, E., Pignotti, E., Rosito, P., & Versari, M. (2004) · European Journal of Cancer · doi:10.1016/j.ejca.2003.08.022 · Cited by 164
The Clinical Management of Chondrosarcoma
Riedel, R. F., Larrier, N., Dodd, L. G., Kirsch, D. G., Martinez, S., & Brigman, B. E. (2009) · Current Treatment Options in Oncology · doi:10.1007/s11864-009-0088-2 · Cited by 162
Andreou, D., Bielack, S. S., Carrle, D., Kevric, M., Kotz, R., Winkelmann, W., Jundt, G., Werner, M., Fehlberg, S., Kager, L., et al. (2011) · Annals of Oncology · doi:10.1093/annonc/mdq589 · Cited by 158
van Doorninck, J., Ji, L., Schaub, B., Shimada, H., Wing, M. R., Krailo, M., Lessnick, S. L., Marina, N. M., Triche, T. J., Sposto, R., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.24.5845 · Cited by 152
Mesenchymal chondrosarcoma of soft tissues and bone in children, adolescents, and young adults
Dantonello, T. M., Int‐Veen, C., Leuschner, I., Schuck, A., Furtwängler, R., Claviez, A., Schneider, D. T., Klingebiel, T., Bielack, S., & Kościelniak, E. (2008) · Cancer · doi:10.1002/cncr.23457 · Cited by 149
Cotterill, S. J., Parker, L., Malcolm, A. J., Reid, M. M., More, L., & Craft, A. W. (2000) · British Journal of Cancer · doi:10.1054/bjoc.2000.1313 · Cited by 146
van der Woude, H.-J., Bloem, J. L., & Hogendoorn, P. C. W. (1998) · Skeletal Radiology · doi:10.1007/s002560050339 · Cited by 142
Bernstein, M. L., Devidas, M., Lafreniere, D., Souid, A.-K., Meyers, P. A., Gebhardt, M. C., Stine, K. C., Nicholas, R. W., Perlman, E. J., Dubowy, R. L., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.02.1717 · Cited by 135
Ferrari, S., Hall, K. S., Luksch, R., Tienghi, A., Wiebe, T., Fagioli, F., Alvegård, T. A., del Prever, A. B., Tamburini, A., Alberghini, M., et al. (2010) · Annals of Oncology · doi:10.1093/annonc/mdq573 · Cited by 126
Survival of children with bone sarcoma in Europe since 1978
Stiller, C. A., Craft, A. W., & Corazziari, I. (2001) · European Journal of Cancer · doi:10.1016/s0959-8049(01)00004-1 · Cited by 122
Radiotherapeutic Factors in the Management of Cervical-basal Chordomas and Chondrosarcomas
Noël, G., Feuvret, L., Ferrand, R., Boisserie, G., Mazeron, J., & Habrand, J. (2004) · Neurosurgery · doi:10.1227/01.neu.0000143330.30405.aa · Cited by 121
Fox, E., PATEL, S. R., Wathen, J. K., Schuetze, S. M., Chawla, S. P., Harmon, D. C., Reinke, D. K., Chugh, R. K., Benjamin, R. S., & Helman, L. J. (2012) · The Oncologist · doi:10.1634/theoncologist.2010-0265 · Cited by 120
Periosteal osteosarcoma – a European review of outcome
Grimer, R. J., Bielack, S., Flege, S., Cannon, S. R., Foleras, G., Andreeff, I., Sokolov, T., Taminiau, A., Dominkus, M., San-Julian, M., et al. (2005) · European Journal of Cancer · doi:10.1016/j.ejca.2005.04.052 · Cited by 110
Do pathological fractures influence survival and local recurrence rate in bony sarcomas?
Bramer, J. A. M., Abudu, A. A., Grimer, R. J., Carter, S. R., & Tillman, R. M. (2007) · European Journal of Cancer · doi:10.1016/j.ejca.2007.07.004 · Cited by 109
Utilization of positron emission tomography in the management of patients with sarcoma
Benz, M., Tchekmedyian, N., Eilber, F. C., Federman, N. C., Czernin, J. G., & Tap, W. D. (2009) · Current Opinion in Oncology · doi:10.1097/cco.0b013e32832c95e2 · Cited by 105
Zoubek, A., Pfleiderer, C., Salzer-Kuntschik, M., Amann, G., Windhager, R. H., Fink, F. M., Kościelniak, E., Delattre, O., Strehl, S., Ambros, P. F., et al. (1994) · British Journal of Cancer · doi:10.1038/bjc.1994.419 · Cited by 103
Yasuda, M., Bresson, D., Chibbaro, S., Cornelius, J. F., Polivka, M., Feuvret, L., Takayasu, M., & George, B. (2011) · Neurosurgical Review · doi:10.1007/s10143-011-0334-5 · Cited by 103
Picci, P., Vanel, D., Briccoli, A., Talle, K., Haakenaasen, U., Malaguti, C., Monti, C., Ferrari, C., Bacci, G., Sæter, G., et al. (2001) · Annals of Oncology · doi:10.1023/a:1013103511633 · Cited by 100
Earlier diagnosis of bone and soft-tissue tumours
Grimer, R. J., & Briggs, T. W. R. (2010) · Journal of Bone and Joint Surgery - British Volume · doi:10.1302/0301-620x.92b11.24326 · Cited by 97
Treatment strategies for metastatic Ewing's sarcoma
Pinkerton, R., Bataillard, A., Guillo, S., Oberlin, O., Fervers, B., & Philip, T. O. (2001) · European Journal of Cancer · doi:10.1016/s0959-8049(01)00131-9 · Cited by 89
Ewing sarcoma: prognostic criteria, outcomes and future treatment
Leavey, P. J., & Collier, A. B. (2008) · Expert Review of Anticancer Therapy · doi:10.1586/14737140.8.4.617 · Cited by 82
Incidence of Biopsy-Proven Bone Tumors in Children
van den Berg, H., Kroon, H. M. J. A., Slaar, A., et al. (2008) · Journal of Pediatric Orthopaedics · doi:10.1097/bpo.0b013e3181558cb5 · Cited by 81
Molecular Diagnosis of Ewing Sarcoma Family of Tumors
Machado, I., Noguera, R., Pellı́n, A., López‐Guerrero, J. A., Piqueras, M., Navarro, S., & Llombart‐Bosch, A. (2009) · Diagnostic Molecular Pathology · doi:10.1097/pdm.0b013e3181a06f66 · Cited by 79
Periosteal osteosarcoma: A single‐institution experience
Cesari, M., Alberghini, M., Vanel, D., Palmerini, E., Staals, E. L., Longhi, A., Abate, M. E., Ferrari, C., Balladelli, A., & Ferrari, S. M. (2010) · Cancer · doi:10.1002/cncr.25718 · Cited by 78
The role of interferons in the treatment of osteosarcoma
Whelan, J., Patterson, D., Perisoglou, M., Bielack, S., Marina, N. M., Smeland, S., & Bernstein, M. L. (2009) · Pediatric Blood & Cancer · doi:10.1002/pbc.22136 · Cited by 69
Response to high‐dose ifosfamide in patients with advanced/recurrent Ewing sarcoma
Ferrari, S., del Prever, A. B., Palmerini, E., Staals, E. L., Berta, M., Balladelli, A., Picci, P., Fagioli, F., Bacci, G., & Vanel, D. (2009) · Pediatric Blood & Cancer · doi:10.1002/pbc.21917 · Cited by 67
Shapeero, L. G., & Vanel, D. (2000) · Seminars in Musculoskeletal Radiology · doi:10.1055/s-2000-6861 · Cited by 60
Bone Cancer Progression and Therapeutic Approaches
Heymann, D. (2009) · Cited by 56
Delaying surgery with chemotherapy for osteosarcoma of the extremities
Bielack, S., Machatschek, J.-N., Flege, S., & Jürgens, H. (2004) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.5.6.1243 · Cited by 48
Recommendations for the reporting of bone tumors
Abdul‐Karim, F. W., Bauer, T. W., Kilpatrick, S. E., et al. (2004) · Human Pathology · doi:10.1016/j.humpath.2004.07.004 · Cited by 33
Complexities in Interpretation of Osteosarcoma Clinical Trial Results
Hunsberger, S., Freidlin, B., & Smith, M. A. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2008.17.3484 · Cited by 30
Berger, M., Grignani, G., Giostra, A., Ferrari, S. M., Ferraresi, V., Tamburini, A., Cefalo, G., Carnevale‐Schianca, F., Vassallo, E., Picci, P., et al. (2011) · Annals of Oncology · doi:10.1093/annonc/mdr542 · Cited by 29
Results of Diagnostic Review in Pediatric Bone Tumors and Tumorlike Lesions
van den Berg, H., Slaar, A., Kroon, H. M. J. A., et al. (2008) · Journal of Pediatric Orthopaedics · doi:10.1097/bpo.0b013e31817bb800 · Cited by 26
Pakos, E. E., Grimer, R. J., Peake, D., Spooner, D. A., Carter, S. R., Tillman, R. M., Abudu, S., & Jeys, L. M. (2011) · Journal of Bone and Joint Surgery - British Volume · doi:10.1302/0301-620x.93b9.27166 · Cited by 20
The final diagnosis in patients with a suspected primary malignancy of bone
Malhas, A., Grimer, R. J., Abudu, A., Carter, S. R., Tillman, R. M., & Jeys, L. M. (2011) · Journal of Bone and Joint Surgery - British Volume · doi:10.1302/0301-620x.93b7.25727 · Cited by 10
Cited by
Riggi, N., Suvà, M. L., & Stamenkovic, I. (2021) · New England Journal of Medicine · doi:10.1056/nejmra2028910 · Cited by 344
Metastatic osteosarcoma: a challenging multidisciplinary treatment
Meazza, C., & Scanagatta, P. (2016) · Expert Review of Anticancer Therapy · doi:10.1586/14737140.2016.1168697 · Cited by 298
UK guidelines for the management of bone sarcomas
On behalf of the British Sarcoma Group, Gerrand, C., Athanasou, N., Brennan, B., Grimer, R., Judson, I., Morland, B., Peake, D., Seddon, B., & Whelan, J. (2016) · Clinical Sarcoma Research · doi:10.1186/s13569-016-0047-1 · Cited by 258
Sundara, Y. T., Kostine, M., Cleven, A. H. G., Bovée, J. V. M. G., Schilham, M. W., & Cleton-Jansen, A.-M. (2017) · Cancer Immunology, Immunotherapy · doi:10.1007/s00262-016-1925-3 · Cited by 111
Palmerini, E., Jones, R. L., Marchesi, E., Paioli, A., Cesari, M., Longhi, A., Meazza, C., Coccoli, L., Fagioli, F., Asaftei, S., et al. (2016) · BMC Cancer · doi:10.1186/s12885-016-2312-3 · Cited by 98
Metadata
- Venue
- Annals of Oncology
- Publisher
- Elsevier BV
- Published
- 2014-09
- Volume
- 25
- Pages
- iii113-iii123
- ISSN
- 0923-7534 (ISSN-L)
- OpenAlex
- W4229894311
- Cited by
- 263
- References
- 90
- FWCI
- 19.14
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.